Opko Health Newswire

Opko Health Newswire

Comprehensive Real-Time News Feed for Opko Health.

Results 1 - 20 of 181 in Opko Health

  1. Insider Buying: Opko Health Inc. (OPK) CEO Purchases 5,400 Shares of StockRead the original story w/Photo

    Friday Feb 5 | AmericanBankingNews.com

    Opko Health Inc. CEO Phillip Md Et Al Frost bought 5,400 shares of the stock in a transaction dated Thursday, February 4th. The stock was purchased at an average cost of $7.91 per share, for a total transaction of $42,714.00.

    Comment?

  2. Fitbit, Tesla Lead List Of Hot Stocks In Short-Selling CirclesRead the original story w/Photo

    Friday Feb 5 | Benzinga

    ... short sellers that are sitting on "attractive gains" appear to be unwilling to close their position. Shares of Opko Health Inc. (NYSE: OPK ) gained around 30 percent during the first half of 2015 while 6 months further on, they were 32 percent lower ...

    Comment?

  3. Opko Health Inc. (OPK) CEO Acquires $127,332.00 in StockRead the original story w/Photo

    Friday Feb 5 | Daily Political

    Opko Health Inc. CEO Phillip Md Et Al Frost acquired 16,200 shares of the company's stock in a transaction dated Monday, February 1st. The stock was bought at an average cost of $7.86 per share, for a total transaction of $127,332.00.

    Comment?

  4. Opko Health Inc. (OPK) Shares Up 8.2% Following Insider Buying ActivityRead the original story w/Photo

    Thursday Feb 4 | Daily Political

    Shares of Opko Health Inc. shot up 8.2% during mid-day trading on Thursday following insider buying activity, MarketBeat Ratings reports. The stock traded as high as $8.47 and last traded at $8.43, with a volume of 3,909,428 shares.

    Comment?

  5. Phillip Md Et Al Frost Acquires 15,400 Shares of Opko Health Inc. (OPK) StockRead the original story w/Photo

    Thursday Feb 4 | Daily Political

    Opko Health Inc. CEO Phillip Md Et Al Frost acquired 15,400 shares of the stock in a transaction dated Wednesday, February 3rd. The shares were bought at an average cost of $7.70 per share, for a total transaction of $118,580.00.

    Comment?

  6. Opko Health Inc. (OPK) CEO Phillip Md Et Al Frost Purchases 35,800 SharesRead the original story w/Photo

    Thursday Feb 4 | Daily Political

    Opko Health Inc. CEO Phillip Md Et Al Frost acquired 35,800 shares of the company's stock in a transaction that occurred on Tuesday, February 2nd. The shares were acquired at an average cost of $7.74 per share, for a total transaction of $277,092.00.

    Comment?

  7. Phillip Md Et Al Frost Buys 16,200 Shares of Opko Health Inc. (OPK) StockRead the original story w/Photo

    Tuesday Feb 2 | AmericanBankingNews.com

    Opko Health Inc. CEO Phillip Md Et Al Frost purchased 16,200 shares of Opko Health stock in a transaction on Monday, February 1st. The stock was purchased at an average price of $7.86 per share, for a total transaction of $127,332.00.

    Comment?

  8. Opko Health Inc. (OPK) Shares Bought by Cardinal Capital ManagementRead the original story w/Photo

    Tuesday Feb 2 | AmericanBankingNews.com

    Cardinal Capital Management increased its stake in shares of Opko Health Inc. by 1.5% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 25,206 shares of the company's stock after buying an additional 383 shares during the period.

    Comment?

  9. Cramer Likes T-Mobile - Cramer's Lightning RoundRead the original story w/Photo

    Friday Jan 29 | Seeking Alpha

    ... CELG ): The stock might get a downgrade and it can go to the low $90s, but investors should buy it then. OPKO Health (NYSE: OPK ): It's speculative but Cramer is a believer in the stock. He advised caution since biotech is under pressure. Cambrex ...

    Comment?

  10. Biotechs aim for noninvasive prostate cancer biopsiesRead the original story w/Photo

    Thursday Jan 28 | CBS News

    What if doctors could screen men for prostate cancer without a painful, and often unneeded, biopsy? A handful of biotech firms are working on techniques that would instead use simple blood or urine tests -- and that could result in a new multibillion-dollar business. A company called OPKO Health has a new procedure involving a blood draw that aims to find whether a man has a dangerous cancer lurking in his prostate -- or not.

    Comment?

  11. Opko Health Inc. (OPK) CEO Phillip Md Et Al Frost Buys 15,000 SharesRead the original story w/Photo

    Wednesday Jan 27 | AmericanBankingNews.com

    Opko Health Inc. CEO Phillip Md Et Al Frost bought 15,000 shares of the company's stock in a transaction on Tuesday, January 26th. The stock was bought at an average price of $7.83 per share, for a total transaction of $117,450.00.

    Comment?

  12. Weekly CEO Buys HighlightsRead the original story w/Photo

    Dec 31, 2014 | GuruFocus.com

    ... by 32.76% since the transaction. bought 102,000 shares during the past week at an average price of $7.96. Opko Health was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. Opko Health has a market cap ...

    Comment?

  13. Opko Health Inc. (OPK) Shares Bought by Boulegeris Investments Inc.Read the original story w/Photo

    Tuesday Jan 26 | AmericanBankingNews.com

    Boulegeris Investments Inc. increased its stake in Opko Health Inc. by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 106,935 shares of the company's stock after buying an additional 650 shares during the period.

    Comment?

  14. Opko Health Inc. (NYSE:OPK) Given Average Recommendation of "Buy" by BrokeragesRead the original story w/Photo

    Monday Jan 25 | AmericanBankingNews.com

    Shares of Opko Health Inc. have been given a consensus rating of "Buy" by the nine brokerages that are presently covering the stock, ARN reports . Four research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company.

    Comment?

  15. Opko Health Inc. (OPK) CEO Phillip Md Et Al Frost Acquires 20,000 SharesRead the original story w/Photo

    Friday Jan 22 | AmericanBankingNews.com

    Opko Health Inc. CEO Phillip Md Et Al Frost purchased 20,000 shares of the stock in a transaction on Thursday, January 21st. The stock was bought at an average price of $7.85 per share, for a total transaction of $157,000.00.

    Comment?

  16. OPKO's GeneDx to Present at Personalized Medicine World ConferenceRead the original story

    Friday Jan 22 | Freshnews

    OPKO Health, Inc. announced today that Marc D. Grodman, MD, Chief Executive Officer of its BioReference/GeneDx subsidiaries, will speak at this year's Personalized Medicine World Conference, Silicon Valley . Dr. Grodman's Presentation, titled "New Model of Clinical Genomics Collaboration", will highlight a unique partnership between GeneDx and health systems to provide a complete genomic solution that facilitates improved patient care, education, research opportunities and commercial R&D collaborations.

    Comment?

  17. Opko Health Inc. (OPK) CEO Acquires $442,430.00 in StockRead the original story w/Photo

    Thursday Jan 21 | AmericanBankingNews.com

    Opko Health Inc. CEO Phillip Md Et Al Frost bought 58,600 shares of the company's stock in a transaction dated Wednesday, January 20th. The stock was bought at an average price of $7.55 per share, for a total transaction of $442,430.00.

    Comment?

  18. Covered Call Alerts For Disney, Opko Health, Celldex Therapeutics,...Read the original story

    Tuesday Jan 19 | Sys-Con Media

    To see the high-return covered-call trades uncovered by InvestorsObserver's analysts, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. Today's PriceWatch Alerts cover the following stocks: Disney , Opko Health , Celldex Therapeutics , Shake Shack , Wynn Resorts .

    Comment?

  19. Opko Health Inc. (OPK) Downgraded by Zacks Investment ResearchRead the original story w/Photo

    Sunday Jan 17 | AmericanBankingNews.com

    According to Zacks, "OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies. " Other analysts also recently issued reports about the stock.

    Comment?

  20. Opko Health Inc. (OPK) CEO Purchases $149,220.00 in StockRead the original story w/Photo

    Thursday Jan 14 | AmericanBankingNews.com

    Opko Health Inc. CEO Phillip Md Et Al Frost purchased 18,000 shares of the business's stock in a transaction that occurred on Wednesday, January 13th. The stock was bought at an average cost of $8.29 per share, with a total value of $149,220.00.

    Comment?